First Trust NYSE Arca Biotechnology Index Fund
64 hedge funds and large institutions have $445M invested in First Trust NYSE Arca Biotechnology Index Fund in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 40 increasing their positions, 7 reducing their positions, and 7 closing their positions.
471% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 7
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
55% more capital invested
Capital invested by funds: $287M → $445M (+$158M)
34% more call options, than puts
Call options by funds: $3.19M | Put options by funds: $2.37M
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
2% more funds holding
Funds holding: 63 → 64 (+1)
30.82% less ownership
Funds ownership: 85.09% → 54.27% (-31%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$47.8M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$25.3M |
| 3 |
Goldman Sachs
New York
|
+$23.9M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$14.5M |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$7.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$27.6M |
| 2 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$7.99M |
| 3 |
Jane Street
New York
|
-$4.63M |
| 4 |
NAM
NTV Asset Management
Charleston,
West Virginia
|
-$1.03M |
| 5 |
PAG
Pinnacle Advisory Group
Columbia,
Maryland
|
-$246K |
FBT Hedge Fund Activity: Q3 2013 in Review
64 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q3 2013, worth a combined $445M — up 55% from $287M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new FBT positions and 7 closed out — a net gain of 1 holder — while 40 added to existing stakes and 7 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $47.8M. The largest seller was Susquehanna International Group, cutting an estimated $27.6M.
- 64 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q3 2013, up from 63 in Q2 2013.
- Funds reported $445M of First Trust NYSE Arca Biotechnology Index Fund stock for Q3 2013, up 55% quarter-over-quarter.
- 8 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q3 2013 and 7 closed out, a net change of +1 holder.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q3 2013 was Morgan Stanley, an estimated $47.8M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q3 2013 was Susquehanna International Group, an estimated $27.6M sold.
Based on aggregated 13F filings for Q3 2013.